Free Trial
LON:FDBK

Feedback (FDBK) Share Price, News & Analysis

Feedback logo
GBX 16.85 -0.05 (-0.30%)
As of 07:16 AM Eastern

About Feedback Stock (LON:FDBK)

Key Stats

Today's Range
16.80
16.85
50-Day Range
16.50
19.75
52-Week Range
16
139
Volume
2,984 shs
Average Volume
108,765 shs
Market Capitalization
£7.38 million
P/E Ratio
N/A
Dividend Yield
4.56%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Feedback plc (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical. Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients. By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers. Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance. CareLocker® is a patient-facing platform that gives patients access and control over their diagnostic and other clinical data. The Company has a number of growth opportunities domestically and internationally across a range of public and private healthcare markets including the NHS. Our highly scalable software-as-a-service (SaaS) based model is expected to provide increasing levels of revenue visibility as the Company grows its customer base.

Remove Ads
Receive FDBK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Feedback and its competitors with MarketBeat's FREE daily newsletter.

FDBK Stock News Headlines

Vicat Q3 2024 Sales
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars
Musk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to help build human colonies on the Red Planet. And here on Earth? Optimus is about to change everything.
Send us a comment
See More Headlines

FDBK Stock Analysis - Frequently Asked Questions

Feedback's stock was trading at GBX 18.50 at the beginning of the year. Since then, FDBK shares have decreased by 8.9% and is now trading at GBX 16.85.
View the best growth stocks for 2025 here
.

Feedback plc (LON:FDBK) posted its quarterly earnings data on Tuesday, February, 25th. The company reported ($14.22) earnings per share (EPS) for the quarter. Feedback had a negative net margin of 279.16% and a negative trailing twelve-month return on equity of 39.71%.

Shares of Feedback reverse split on the morning of Friday, October 14th 2022. The 1-200 reverse split was announced on Friday, October 14th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, October 14th 2022. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Shares of FDBK stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Feedback investors own include 4D pharma (DDDD), Omega Diagnostics Group (ODX), Quadrise Fuels International (QFI), Advanced Oncotherapy (AVO), B&M European Value Retail (BME), Coats Group (COA) and genedrive (GDR).

Company Calendar

Last Earnings
2/25/2025
Today
4/01/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
Current Symbol
LON:FDBK
CIK
N/A
Fax
N/A
Employees
24
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£-10,841,180.82
Net Margins
-279.16%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£3.88 million
Cash Flow
GBX 15.06 per share
Price / Cash Flow
1.12
Book Value
GBX 57.35 per share
Price / Book
0.29

Miscellaneous

Free Float
N/A
Market Cap
£7.38 million
Optionable
Not Optionable
Beta
0.77
7 Top Nuclear Stocks To Buy Now Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (LON:FDBK) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners